FCJ-14986-94634
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 620 / IL
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-10
Registered in v-safe
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Muscle or body achesAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-03-31
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-09
- 2021-09-08
-
2021-10-29
Dose 2 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-11-01
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Fatigue or tirednessFree text: Sneezing/runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-14
- 2021-11-20
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
-
2022-10-13
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-18
- 2022-10-22
- 2022-11-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Pfizer-BioNTech | Flu |
| 3 | 2022-10-13 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Sneezing/runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release